PROTEONOMIX, INC. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.
Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.
“Proteonomix has made great strides recently,” stated Mr. Cohen, “and we have been contacted by several European entities that have requested additional information about our proprietary stem cell activities. In recognition of the interest in Europe and the potential for additional joint venture agreements in various European countries, we recognize that it is propitious to meet with a number of the European institutional investors both to educate them on the intrinsic value of Proteonomix shares and garner interest in strategic relationships.”
Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (“PRTMI”) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.
Chemspec International Limited (NYSE: CPC), a leading China-based contract manufacturer of highly-engineered specialty chemicals, has authorized a share repurchase program that would allow the Company to repurchase up to US$10 million of its American Depositary Shares (“ADSs”) on the open market between September 22, 2010 and September 21, 2011.
The repurchases will be made from time to time on the open market at prevailing market prices. The timing and extent of any purchases will depend upon market conditions, the trading price of the ADSs and other factors, and will be subject to restrictions relating to volume, price and timing under applicable laws, including Rule 10b-18 of the Securities Exchange Act of 1934.
Chemspec is a leading China-based contract manufacturer of highly engineered specialty chemicals as well as fluorinated specialty chemicals. In manufacturing specialty chemicals, Chemspec also provides process design and process development services, which enable efficient and rapid production of specialty chemicals that are incorporated into the products of Chemspec’s end users. Chemspec’s customers and end users include electronics, pharmaceutical and agrochemical companies.
Cherokee Inc. (NASDAQ:CHKE), a leading global licensor and brand management company, reported total royalty revenues for the second quarter ended July 31, 2010 of $7.5 million, as compared to $8.1 million in the comparable period last year. Cherokee�s operating expenses for the Second Quarter totaled $3.36 million, which was slightly greater than the $3.34 million in the comparable period last year. Cherokee�s net income for the Second Quarter decreased by a total of $0.4 million to $2.5 million or $0.28 per diluted share, as compared to $2.9 million, or $0.32 per diluted share in the comparable period last year. The Company ended the quarter with cash and cash equivalents of $7.3 million, net receivables of $6.7 million and no debt.
Russell J. Riopelle, Chief Financial Officer, commented, �We finished the quarter in another strong cash position and a debt-free balance sheet. During our Second Quarter we paid a $0.38 per share dividend in June, and announced our September dividend of $0.38 per share.�
Howard Siegel, Chief Operating Officer of Cherokee, stated, �Slight increases in our U.S. royalties were offset by less favorable exchange rates and lower royalties from certain international accounts.�
Cherokee Inc., is a worldwide marketer and manager of brands it owns (Cherokee, Sideout, Carole Little and others) and represents. Currently, Cherokee has licensing agreements in a number of categories, including family apparel, fashion accessories and footwear, as well as home furnishings and recreational products. Premier clients for the Cherokee brand around the world include Target Stores (U.S.), Tesco (U.K., Ireland and certain Central European countries), Zellers (Canada), Pick �n Pay (South Africa), Falabella (Chile, Peru and Colombia), Arvind Mills (India and certain Middle Eastern countries), Shufersal LTD. (Israel), Comercial Mexicana (Mexico), Eroski (Spain) and RT-Mart (Peoples Republic of China). Premiere clients for Cherokee�s other brands include the TJX Companies (U.S., Canada and Europe) for the Carole Little brands, and Shanghai Bolderway (China) and for the Sideout Brand. Cherokee also placed the Laila Ali brand with IBB for beauty and personal care.
Chesapeake Energy Corporation (NYSE:CHK) will host its 2010 Institutional Investor and Analyst Meeting on Wednesday, October 13, in Oklahoma City, OK.
The meeting will be webcast live on Chesapeake�s website from 9:00 am EDT to 3:00 pm EDT on Wednesday, October 13. The webcast and presentation material can be accessed by going to Chesapeake�s website at www.chk.com and selecting the �Events� subsection of the �Investors� section on the website. The replay of the webcast will be available on the website approximately two hours after the conclusion of the event and will be accessible for two weeks.
Chesapeake Energy Corporation is the second-largest producer of natural gas and the most active driller of new wells in the U.S.Headquartered in Oklahoma City, the company’s operations are focused on discovering and developing unconventional natural gas and oil fields onshore in the U.S.Chesapeake owns leading positions in the Barnett, Fayetteville, Haynesville, Marcellus and Bossier natural gas shale plays and in the Eagle Ford, Granite Wash and various other unconventional liquids plays.The company has also vertically integrated its operations and owns substantial midstream, compression, drilling and oilfield service assets.
No comments:
Post a Comment